
In collaboration with the Dutch biotech company Mucosis and University of Copenhagen, the Danish company ExpreS2ion Biotechnologies has been awarded so-called Eurostar funding from the EU.
The two biotech companies and the university will work together on the further development of a malaria vaccine for pregnant women. ExpreS2ion Biotechnologies is already developing the vaccine with funding from The Danish National Advanced Technology Foundation.
Allerede abonnent? Log ind.
Læs hele artiklen
Få adgang i 14 dage for 0 kr.
Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.
- Adgang til alle låste artikler
- Modtag vores daglige nyhedsbreve
- Fuld adgang til vores app